✦ LIBER ✦

Glatiramer acetate: A novel therapeutic approach in Crohn's disease?

✍ Scribed by Albrecht Neesse; Patrick Michl; Steffen Kunsch; Thomas M. Gress; Martin Steinkamp

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 103 KB
Volume: 15
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20537

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel approach to the sticky business

A novel approach to the sticky business of Crohn's disease therapy

✍ Charles N. Bernstein 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Endoscopic balloon dilatation as a thera

Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn's disease

✍ A. J. K. Williams; Mr K. R. Palmer 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views

PGC-1α activation as a therapeutic appro

PGC-1α activation as a therapeutic approach in mitochondrial disease

✍ Tina Wenz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

## Abstract Mitochondria play a central role in cellular homeostasis. Hence, mitochondrial dysfunction resulting in impaired ATP supply is detrimental to cell viability and causes severe and often fatal disorders. Current treatment of these mitochondrial disorders is limited and mostly addresses th

Combined approach with infliximab, surge

Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: Results from a prospective study

✍ Pauline Roumeguère; Dominique Bouchard; François Pigot; Alain Castinel; Frederic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Background: Infliximab is the only medical therapy that has been proven to be effective in fistulizing Crohn's disease (CD), but the recurrence rate of fistulas is high despite maintenance therapy. The aim of this prospective study was to evaluate the short-and long-term efficacy of a combined sched

A novel protein degradation system in yo

A novel protein degradation system in young-onset Parkinson's disease: Mitophagy is a therapeutic target as a quality control for damaged mitochondria

✍ Taku Hatano 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Use of a novel vitamin D bioavailability

Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent crohn's disease

✍ F.A. Farraye; H. Nimitphong; A. Stucchi; K. Dendrinos; A.B. Boulanger; A. Vijjes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

## Background: Vitamin d deficiency is a common problem in patients with crohn's disease (cd). the aim of this study was to determine the ability of normal subjects and patients with quiescent cd to absorb vitamin d(2) using a novel vitamin d bioavailability test. in addition, we evaluated whether